Febuxostat Tablets

Description

Febujey-40 by Ellanjey is a potent, selective xanthine oxidase inhibitor containing Febuxostat 40 mg in a convenient film-coated tablet formulation. Febuxostat is a modern, non-purine selective inhibitor of xanthine oxidase – the key enzyme responsible for the conversion of hypoxanthine to xanthine and xanthine to uric acid in the purine metabolism pathway. By selectively inhibiting xanthine oxidase, Febuxostat effectively reduces the production of uric acid, leading to decreased serum uric acid levels and prevention of gout flares.

Key Benefits:

• Potent xanthine oxidase inhibitor – Reduces uric acid production effectively

• Non-purine structure – No purine-related hypersensitivity reactions

• Dual enzyme inhibition – Blocks both oxidized & reduced forms of xanthine oxidase

• Renal dosing flexibility – No dose adjustment in mild-to-moderate renal impairment

• Once-daily dosing – Convenient for long-term chronic therapy

FAQs:

1. What is Febujey-40 used for?
Febujey-40 is used for chronic management of hyperuricemia (high uric acid levels) in patients with gout. It prevents gout flares but does NOT treat acute gout attacks.

2. How should I take Febujey-40 tablets?
Take exactly as prescribed, usually 40 mg once daily. Swallow the tablet whole with water, with or without food. Do not stop taking it even if you feel well – gout requires lifelong therapy.

3. What are the common side effects?
Common side effects include liver function test abnormalities, nausea, diarrhea, headache, joint pain (gout flares during initial therapy), and rash. Regular liver function monitoring is recommended.

4. Can I take Febujey-40 during an acute gout attack?
Yes, continue Febujey-40 if you are already on it. If you are starting Febujey-40 for the first time, wait until the acute attack resolves. Treat the acute attack with NSAIDs or colchicine.